HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Cabaletta Bio (NASDAQ:CABA) and maintained a $30 price target.
May 24, 2024 | 10:31 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Cabaletta Bio and maintained a $30 price target.
The reiteration of a Buy rating and a maintained price target of $30 by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100